Page last updated: 2024-08-17

quinoxalines and Ocular Hypertension

quinoxalines has been researched along with Ocular Hypertension in 151 studies

Research

Studies (151)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (0.66)	18.7374
1990's	22 (14.57)	18.2507
2000's	94 (62.25)	29.6817
2010's	30 (19.87)	24.3611
2020's	4 (2.65)	2.80

Authors

Authors	Studies
Inoue, K; Ishida, K; Kunimatsu-Sanuki, S; Tomita, G	1
Aihara, M; Kanazawa, M; Kawakita, K; Kojima, S; Nojima, T; Suganami, H; Tanihara, H; Yamamoto, T	1
Kim, KE; Kim, Y; Lee, CK; Rho, S; Shin, J	1
Aihara, M; Isobe, T; Kanazawa, M; Koizumi, N; Kojima, S; Minami, H; Suganami, H; Tanihara, H; Yamamoto, T	1
Goode, SM; McMenemy, MG; Nguyen, QH; Realini, T; Whitson, JT	1
Dubiner, H; Katz, G; Sall, K; Samples, J; Vold, S	1
Bonini-Filho, MA; Costa, R; Jorge, R; Katayama, BY; Martin, LF; Messias, AM; Paula, JS	1
DuBiner, H; Katz, G; Nguyen, QH; Realini, T	1
Baser, EF; Gülhan, C; Öztürk, B; Seymenoğlu, G	1
Campagna, O; Colica, C; Cruciani, F; De Vico, U; Gharbiya, M	1
Cherukury, M; Durairaj, C; Shen, J	1
Chi, W; Li, A; Wang, S; Zhu, X	1
Aung, T; Branch, JD; Goldberg, I; Hernandez Paredes, TJ; Laganovska, G; Tsorbatzoglou, A	1
Gandolfi, SA; Hamacher, T; Lim, J; Parra Restrepo, JC; Sanseau, AC	1
Agarwal, P; Agarwal, R; Ismail, NM; Kannan Kutty, M; Kapitonova, MY; Razali, N; Salmah Bakar, N; Smirnov, A	1
García-López, A; Hartleben, C; Jiménez-Román, J; Paczka, JA	1
Batoosingh, AL; Cantor, LB; Liu, CC; Safyan, E	1
Batiste, C; Fudemberg, SJ; Katz, LJ	1
Barbosa, WL; Grigera, DE; Hatanaka, M; Jordao, M; Susanna, R	1
Jewelewicz, DA; Liebmann, J; Radcliffe, NM; Ritch, R	1
Delgado-Ortega, L; Díaz-Cerezo, S; Pinazo-Durán, MD; Soto-Alvarez, J; Vinuesa-Silva, I; Vinuesa-Silva, JM	1
Batoosingh, AL; Cantor, LB; Hollander, DA; Liu, CC	1
Chartrand, JP; Hollander, DA; Nixon, DR; Piemontesi, RL; Simonyi, S; Yan, DB	1
Bournias, TE; Lai, J	1
Gul, M; Imrek, S; Ozdemir, G; Tolun, FI	1
Brinkmann, CK; Katsimpris, JM; Lepidas, J; Livieratou, A; Petropoulos, IK; Theoulakis, PE	1
Calvo-González, C; Fernández-Vidal, A; García-Feijoó, J; García-Sánchez, J; Martínez-de-la-Casa, JM; Méndez-Hernández, C; Sáenz-Francés, F	1
Liu, JH; Medeiros, FA; Slight, JR; Weinreb, RN	1
Bron, AM; Creuzot-Garcher, CP; Diestelhorst, M; Hermann, MM	1
Artunay, O; Bahcecioglu, H; Rasier, R; Sengul, A; Unal, M; Yuzbasioglu, E	1
Diestelhorst, M; Georgopoulos, G; Hermann, MM; Muether, PS; Papaconstantinou, D	1
Bernstein, P; Caprioli, J; Schiffman, RM; Spaeth, GL	1
Hendrikse, F; Peeters, A; Prins, MH; Schouten, JS; Webers, CA	1
Georgakopoulos, CD; Giannopoulos, K; Makri, OE; Pharmakakis, N; Stasinos, S	1
Abdlseaed, AA; Abeysinghe, SS; Kelly, S; Montgomery, DM; Rahman, MQ; Roskell, NS; Shannon, PR	1
García-Pérez, JL; González-Gordaliza, C; Muñoz-Negrete, FJ; Puerto-Hernández, B; Rebolleda, G	1
Liu, JH; Realini, T; Weinreb, RN	1
Grover, DS; Smith, O	1
Cottingham, AJ; Hollander, DA; Katz, LJ; Rauchman, SH; Schiffman, RM; Simmons, ST; Williams, JM	1
Chen, DF; Chen, H; Cho, KS; Guo, W; Luo, G; Pang, IH; Wang, WH; Yang, Q; Yu, D	1
Garhöfer, G; Hommer, A; Popa-Cherecheanu, A; Qiao, C; Resch, H; Schmetterer, L; Sperl, P	1
Dot, C; El Chehab, H; Giraud, JM; Le Corre, A; Ract-Madoux, G; Swalduz, B	1
Araie, M; Kuwayama, Y; Sugiyama, K; Tanihara, H; Yamazaki, Y	1
Day, DG; Ellyn, J; Kulze, J; Leech, J; Sharpe, ED; Stewart, WC	1
Baudouin, C; Titouamane, S	1
Bottoli, A; Fogagnolo, P; Fumagalli, E; Invernizzi, T; Orzalesi, N; Rossetti, I	1
Matthews, TD; Mushtaq, B; Sardar, J	1
Camras, CB	2
Ge, J; Li, Y; Yu, M	1
Jiang, YQ; Shi, JM	1
Boyle, DR; Cassel, DA; DeLucca, PT; Fletcher, CA; Greff, LJ; Johnson-Pratt, LR; Kolodny, AH; Polis, AB; Sall, KN; Skobieranda, F	1
Batoosingh, A; Felix, C; Mundorf, T; Whitcup, S; Williams, R	1
Bottoli, A; Fogagnolo, P; Fumagalli, E; Orzalesi, N; Rossetti, L	1
Hommer, A; Kapik, B; Shams, N	1
Ermis, SS; Inan, UU; Oztürk, F; Yücel, A	1
Day, D; Sharpe, ED; Stewart, JA; Stewart, WC	1
Abraham, LM; George, R; Muliyil, J; Parikh, R; Paul, P; Thomas, R	1
Gerodimos, G; Katsimpris, JM; Petropoulos, IK; Pharmakakis, NM; Voros, G	1
Mozaffari, E; Reardon, G; Schwartz, GF	1
Ratan, J; Sodhi, PK; Verma, L	1
Georgiadis, N; Katsimpris, JM; Konstas, AG; Kozobolis, V; Siganos, D	1
Day, DG; Jenkins, JN; Sharpe, ED; Stewart, JA; Stewart, WC	1
Day, DG; Jenkins, J; Stewart, JA; Stewart, WC	1
Day, DG; Henry, CJ; Jenkins, JN; Mundorf, TK; Sharpe, ED; Stewart, JA; Stewart, WC	1
Cassel, DA; DeLucca, PT; Hustad, CM; Kolodny, AH; Skobieranda, F; Solish, AM	1
Fechtner, RD; Henry, C; Hughes, B; Lee, DA; Terry, S; Whitson, JT	1
Arias Puente, A; Carrasco Font, C; García Sáenz, MC; Villarejo Díaz-Maroto, I	1
Cunliffe, I; García-Sánchez, J; Landry, J; Pajic, B; Rouland, JF; Spiegel, D; Traverso, C	1
Beischel, CJ; Day, DG; Rhodes, JS; Sharpe, ED; Stewart, JA; Stewart, WC	1
Akman, A; Akova, YA; Cetinkaya, A	1
Camras, CB; Sheu, WP	1
Călugăru, D; Călugăru, M	1
Cheetham, JK; Chou, C; Craven, ER; Schiffman, R; Walters, TR; Williams, R	1
Chen, TC	1
Márquez-de-Aracena, R; Montero-de-Espinosa, I; Morales, C	1
Avila, MP; Magacho, L; Queiroz, CF; Reis, R; Santos, LC	1
Aloni, E; Bakalash, S; Ben Simon, GJ; Rosner, M	1
Carassa, R; Gandolfi, S; Manni, G; Marchini, G; Mastropasqua, L; Montanari, P; Orzalesi, N; Quaranta, L; Ratiglia, R; Rossetti, L; Traverso, C; Uva, M	1
Hong, YJ; Lee, JH; Seong, GJ; Yeom, HY	1
Iveković, R; Korsić, J; Mandić, Z; Masnec-Paskvalin, S; Novak-Laus, K; Zorić-Geber, M	1
Andrew, RM; Bergamini, MV; Bosworth, CF; Dickerson, JE; James, JE; Landry, TA; Moster, MR; Ochsner, KI; Silver, LH; Sullivan, EK; Wells, DT; Whitson, JT	1
Craig, JC; Fung, AT; Healey, PR; Jones, MP; McCluskey, PJ; Reid, SE	1
Batoosingh, AL; Chou, C; Craven, ER; DuBiner, HB; Schiffman, RM; Sherwood, MB; Whitcup, SM	1
Frampton, JE	1
Goñi, FJ	1
Andreo, EG; Arcieri, ES; Arcieri, RS; Finotti, IG; Pereira, AC; Sá Filho, WF	1
Alvarado, JA	1
Baker, L; Chuang, AZ; Feldman, RM; Gross, RL; Prager, TC; Reynolds, A; Tanna, AP	1
Georgiadou, I; Kaltsos, K; Katsimpris, IE; Konstas, AG; Kordelou, A; Nelson, LA; Stewart, WC	1
Hong, S; Kim, CY; Seong, GJ	1
Craven, ER; Katz, LJ; Simmons, ST	1
Akman, A; Akova, YA; Borazan, M; Karalezli, A	1
Comez, A; Dogan, OK; Karacan, O; Oral, Y; Ozkurt, Y	1
Day, DG; Hollander, DA	1
Camras, CB; Gleason, ML; Toris, CB; Yablonski, ME	1
Barnebey, HS; Chen, KS; Cinotti, DJ; Coleman, AL; Hersh, SB; Lewis, RA; Morrison, JC; Robin, AL; Walt, J; Zimmerman, TJ	1
Clevenger, CE; David, R; Henry, JC; Passo, MS; Perell, HF; Siegel, LI; Spaeth, GL; Stamper, RL; Stiles, MC; Walt, JG	1
Burke, J; Schwartz, M	1
Schuman, JS	2
Walters, TR	1
Serle, JB	1
Barnebey, HS; Chen, K; Choplin, N; Derick, RJ; Kelley, EP; Robin, AL; Schuman, J; Stoecker, JF; Walters, TR	1
Albracht, D; Chen, K; Choplin, NT; David, R; Horwitz, B; Schuman, JS	1
Greenfield, DS; Liebmann, JM; Ritch, R	1
Adkins, JC; Balfour, JA	1
Carpineto, P; Ciancaglini, M; Mastropasqua, L	1
LeBlanc, RP	1
Dhanjil, S; Lachkar, Y; Migdal, C	1
Katz, LJ	2
Burnstein, Y; Robin, AL	1
Assalian, A; Chevrier, RL; Duperré, J; Lesk, MR	1
Barbe, ME; Carlsen, JO; Kwon, YH; Scott, WE; Zabriskie, NA	1
Camras, CB; Toris, CB; Yablonski, ME	1
Barnes, SD; Campagna, JA; Dirks, MS; Doe, EA	1
Carlsson, AM; Chauhan, BC; Leblanc, RP; Lee, AA	2
Abrams, C; Gornbein, J; Lee, DA	1
Lee, DA	1
David, R; Melamed, S	1
Connor, TB; Dev, S; Han, DP; Mieler, WF; Mittra, RA; Pollack, JS; Pulido, JS	1
Lee, BH; Ma, YR; Park, YG; Yang, KJ	1
Samuelson, TW; Simmons, ST	1
Chopra, H; Day, DG; Holmes, KT; Kolker, AE; Konstas, AG; Lee, WH; Rieser, JC; Sharpe, ED; Stewart, WC	1
Javitt, JC; Schiffman, RM	1
Day, DG; Harbin, TS; Holmes, KT; Pastor, SA; Sharpe, ED; Stewart, JA; Stewart, WC	1
Detry-Morel, M; Dutrieux, C	1
Goldberg, I; Javitt, J	1
Whitehouse, G	1
Day, DG; Holmes, KT; Leech, JN; Rowan, CT; Schwartz, GF; Stewart, JA; Stewart, WC	1
Cantor, LB	1
Day, DG; Latham, KE; Schuhr, J; Stewart, JA; Stewart, WC	1
Simmons, ST	1
Gil, DW; Wheeler, LA; WoldeMussie, E	1
Ang, RT; Chen, TC; Fan, JT; Grosskreutz, CL; Pasquale, LR	1
Holmes, KT; Johnson, MA; Stewart, WC	1
Gornbein, JA; Lee, DA	1
Coulibaly, R	1
Cantor, LB; Flartey, K; Hoop, J; Katz, LJ	1
Findl, O; Georgopoulos, M; Kiss, B; Menapace, R; Petternel, V; Rainer, G	1
Ruiz, G; Wheeler, LA; Wijono, M; WoldeMussie, E	1
McKinnon, S; Paris, G; Pena, M; Sanford, K; Sponsel, WE; Trigo, Y; Weber, A	1
Dirks, MS; DuBiner, HB; Mroz, M; Shapiro, AM	1
Earl, ML; Simmons, ST	1
Arias-Puente, A; Kampik, A; O'Brart, DP; Vuori, ML	1
Kasahara, N	1
Hawksworth, N; Watts, P	1
Benozzi, J; Campanelli, JL; Nahum, LP; Rosenstein, RE	1
Burke, JA; Potter, DE	1

Reviews

13 review(s) available for quinoxalines and Ocular Hypertension

Article	Year
Efficacy, safety, and current applications of brimonidine. Expert opinion on drug safety, 2008, Volume: 7, Issue:6 Topics: Animals; Antihypertensive Agents; Brimonidine Tartrate; Drug Combinations; Glaucoma; Humans; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Timolol; Treatment Outcome	2008
[Development of conjunctival hyperemia with the use of a fixed combination of latanoprost/timolol: systematic review and meta-analysis of clinical trials]. Archivos de la Sociedad Espanola de Oftalmologia, 2009, Volume: 84, Issue:4 Topics: Aged; Brimonidine Tartrate; Clinical Trials as Topic; Cloprostenol; Conjunctival Diseases; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Glaucoma; Humans; Hyperemia; Latanoprost; Middle Aged; Ocular Hypertension; Odds Ratio; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Timolol; Travoprost	2009
Safety and tolerability of brimonidine purite 0.1% and brimonidine purite 0.15%: a meta-analysis of two phase 3 studies. Current medical research and opinion, 2009, Volume: 25, Issue:7 Topics: Antihypertensive Agents; Brimonidine Tartrate; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Osmolar Concentration; Quinoxalines; Randomized Controlled Trials as Topic; Withholding Treatment	2009
Recent clinical pearls from clinical trials in glaucoma. Current opinion in ophthalmology, 2012, Volume: 23, Issue:2 Topics: Antihypertensive Agents; Brimonidine Tartrate; Clinical Trials as Topic; Filtering Surgery; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Low Tension Glaucoma; Ocular Hypertension; Quinoxalines; Timolol; Tonometry, Ocular	2012
[Latanoprost topical ophthalmic combinations]. Oftalmologia (Bucharest, Romania : 1990), 2004, Volume: 48, Issue:4 Topics: Acetazolamide; Administration, Topical; Antihypertensive Agents; Brimonidine Tartrate; Dinoprost; Drug Combinations; Drug Therapy, Combination; Epinephrine; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Timolol	2004
Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma. The British journal of ophthalmology, 2007, Volume: 91, Issue:1 Topics: Administration, Topical; Aged; Antihypertensive Agents; Brimonidine Tartrate; Female; Glaucoma; Glaucoma, Open-Angle; Humans; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Randomized Controlled Trials as Topic; Treatment Outcome	2007
Topical brimonidine 0.2%/timolol 0.5% ophthalmic solution: in glaucoma and ocular hypertension. Drugs & aging, 2006, Volume: 23, Issue:9 Topics: Antihypertensive Agents; Brimonidine Tartrate; Clinical Trials as Topic; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Timolol; Treatment Outcome	2006
Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension. Current medical research and opinion, 2007, Volume: 23, Issue:12 Topics: Antihypertensive Agents; Brimonidine Tartrate; Clinical Trials as Topic; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Male; Ocular Hypertension; Quinoxalines; Sulfonamides; Thiophenes; Treatment Outcome	2007
Preclinical evaluation of brimonidine. Survey of ophthalmology, 1996, Volume: 41 Suppl 1 Topics: Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Cats; Cebus; Drug Evaluation, Preclinical; Glaucoma; Humans; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Rabbits; Rats	1996
Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: a review of safety, efficacy, dose response, and dosing studies. Survey of ophthalmology, 1996, Volume: 41 Suppl 1 Topics: Acute Disease; Adrenergic alpha-Agonists; Brimonidine Tartrate; Clinical Trials as Topic; Dose-Response Relationship, Drug; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Safety	1996
Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment. Journal of glaucoma, 1997, Volume: 6, Issue:4 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Betaxolol; Brimonidine Tartrate; Clinical Trials as Topic; Dose-Response Relationship, Drug; Glaucoma; Humans; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Timolol; Trabeculectomy	1997
Brimonidine. A review of its pharmacological properties and clinical potential in the management of open-angle glaucoma and ocular hypertension. Drugs & aging, 1998, Volume: 12, Issue:3 Topics: Adrenergic alpha-Agonists; Aged; Brimonidine Tartrate; Clinical Trials as Topic; Glaucoma, Open-Angle; Humans; Ocular Hypertension; Quinoxalines	1998
The evolving pharmacotherapeutic profile of brimonidine, an alpha 2-adrenergic agonist, after four years of continuous use. Expert opinion on pharmacotherapy, 2000, Volume: 1, Issue:4 Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Glaucoma; Humans; Neuroprotective Agents; Ocular Hypertension; Quinoxalines; Receptors, Adrenergic, alpha-2	2000

Trials

105 trial(s) available for quinoxalines and Ocular Hypertension

Article	Year
Ripasudil-Brimonidine Fixed-Dose Combination vs Ripasudil or Brimonidine: Two Phase 3 Randomized Clinical Trials. American journal of ophthalmology, 2023, Volume: 248 Topics: Antihypertensive Agents; Brimonidine Tartrate; Double-Blind Method; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertension; Prospective Studies; Quinoxalines; Randomized Controlled Trials as Topic; Treatment Outcome	2023
Comparisons of efficacy and safety between preserved and preservative-free brimonidine tartrate in glaucoma and ocular hypertension: a parallel-grouped, randomized trial. Scientific reports, 2023, 04-07, Volume: 13, Issue:1 Topics: Antihypertensive Agents; Brimonidine Tartrate; Double-Blind Method; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Preservatives, Pharmaceutical; Quinoxalines; Treatment Outcome	2023
Crossover Randomized Study of Pharmacologic Effects of Ripasudil-Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine. Advances in therapy, 2023, Volume: 40, Issue:8 Topics: Adult; Antihypertensive Agents; Brimonidine Tartrate; Endothelial Cells; Glaucoma, Open-Angle; Humans; Hyperemia; Intraocular Pressure; Male; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quinoxalines	2023
Phase 3 randomized 3-month trial with an ongoing 3-month safety extension of fixed-combination brinzolamide 1%/brimonidine 0.2%. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2013, Volume: 29, Issue:3 Topics: Administration, Ophthalmic; Adrenergic alpha-2 Receptor Agonists; Aged; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Quinoxalines; Sulfonamides; Thiazines; Time Factors; Treatment Outcome	2013
Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%. JAMA ophthalmology, 2013, Volume: 131, Issue:6 Topics: Academic Medical Centers; Administration, Ophthalmic; Adrenergic alpha-2 Receptor Agonists; Aged; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Diagnostic Techniques, Ophthalmological; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Least-Squares Analysis; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Predictive Value of Tests; Private Practice; Quinoxalines; Sulfonamides; Thiazines; Time Factors; Treatment Outcome; United States	2013
Comparison of acetazolamide, brimonidine, and anterior chamber paracentesis for ocular hypertension control after initial intravitreal bevacizumab injection: a randomized clinical trial. Journal of glaucoma, 2014, Volume: 23, Issue:7 Topics: Acetazolamide; Administration, Oral; Administration, Topical; Aged; Angiogenesis Inhibitors; Anterior Chamber; Antibodies, Monoclonal, Humanized; Antihypertensive Agents; Bevacizumab; Brimonidine Tartrate; Female; Humans; Intraocular Pressure; Intravitreal Injections; Male; Middle Aged; Ocular Hypertension; Paracentesis; Quinoxalines; Tonometry, Ocular	2014
Fixed-combination brinzolamide 1%/brimonidine 0.2% vs monotherapy with brinzolamide or brimonidine in patients with open-angle glaucoma or ocular hypertension: results of a pooled analysis of two phase 3 studies. Eye (London, England), 2013, Volume: 27, Issue:7 Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Quinoxalines; Sulfonamides; Thiazines; Visual Acuity	2013
Comparison of dorzolamide/timolol versus brimonidine/timolol fixed combination therapy in the management of steroid-induced ocular hypertension. Journal of glaucoma, 2015, Volume: 24, Issue:2 Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Diabetic Retinopathy; Drug Combinations; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Triamcinolone Acetonide	2015
Efficacy of combined administration of 0.2% brimonidine and 0.5% betaxolol in treatment of primary open angle glaucoma and ocular hypertension. Eye science, 2013, Volume: 28, Issue:4 Topics: Aged; Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Drug Administration Schedule; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ocular Hypotension; Quinoxalines; Tonometry, Ocular; Treatment Outcome	2013
Twice-daily brinzolamide/brimonidine fixed combination versus brinzolamide or brimonidine in open-angle glaucoma or ocular hypertension. Ophthalmology, 2014, Volume: 121, Issue:12 Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Sulfonamides; Thiazines	2014
Randomized trial of brinzolamide/brimonidine versus brinzolamide plus brimonidine for open-angle glaucoma or ocular hypertension. Advances in therapy, 2014, Volume: 31, Issue:12 Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Quinoxalines; Sulfonamides; Thiazines; Tonometry, Ocular; Treatment Outcome	2014
Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study. BMC ophthalmology, 2014, Dec-19, Volume: 14 Topics: Administration, Topical; Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Circadian Rhythm; Cloprostenol; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Treatment Outcome	2014
Brimonidine-purite 0.1% versus brimonidine-purite 0.15% twice daily in glaucoma or ocular hypertension: a 12-month randomized trial. Current medical research and opinion, 2008, Volume: 24, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Double-Blind Method; Drug Administration Schedule; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Quinoxalines; Treatment Outcome	2008
An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/ Journal of glaucoma, 2008, Volume: 17, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Circadian Rhythm; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Treatment Outcome; Young Adult	2008
Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy. Current medical research and opinion, 2009, Volume: 25, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Drug Combinations; Female; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Osmolar Concentration; Quinoxalines; Sulfonamides; Thiophenes; Time Factors; Timolol	2009
Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs. Ophthalmology, 2009, Volume: 116, Issue:9 Topics: Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Cloprostenol; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Single-Blind Method; Sulfonamides; Thiazines; Thiophenes; Tonometry, Ocular; Travoprost; Treatment Outcome	2009
Effect of brimonidine/timolol fixed combination on preventing the short-term intraocular pressure increase after intravitreal injection of ranibizumab. Klinische Monatsblatter fur Augenheilkunde, 2010, Volume: 227, Issue:4 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antihypertensive Agents; Brimonidine Tartrate; Double-Blind Method; Drug Combinations; Female; Humans; Injections, Intralesional; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Placebo Effect; Quinoxalines; Ranibizumab; Timolol; Treatment Outcome; Vitreous Body	2010
Comparison of ocular hypotensive actions of fixed combinations of brimonidine/timolol and dorzolamide/timolol. Current medical research and opinion, 2010, Volume: 26, Issue:7 Topics: Aged; Aged, 80 and over; Algorithms; Antihypertensive Agents; Brimonidine Tartrate; Cross-Over Studies; Dosage Forms; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Sulfonamides; Thiophenes; Timolol	2010
Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring. Journal of glaucoma, 2011, Volume: 20, Issue:8 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Drug Monitoring; Female; Glaucoma, Open-Angle; Health Behavior; Humans; Intraocular Pressure; Low Tension Glaucoma; Male; Medication Adherence; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quinoxalines; Tonometry, Ocular	2011
Bimatoprost 0.03% versus brimonidine 0.2% in the prevention of intraocular pressure spike following neodymium:yttrium–aluminum–garnet laser posterior capsulotomy. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2010, Volume: 26, Issue:5 Topics: Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Capsule Opacification; Cataract; Cloprostenol; Female; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Lasers, Solid-State; Male; Middle Aged; Neodymium; Ocular Hypertension; Ophthalmic Solutions; Posterior Capsule of the Lens; Quinoxalines; Tonometry, Ocular	2010
Adherence with brimonidine in patients with glaucoma aware and not aware of electronic monitoring. Acta ophthalmologica, 2011, Volume: 89, Issue:4 Topics: Administration, Topical; Adult; Aged; Antihypertensive Agents; Brimonidine Tartrate; Drug Monitoring; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Medication Adherence; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Patient Compliance; Prospective Studies; Quinoxalines; Visual Acuity	2011
Control of intraocular pressure and fluctuation with fixed-combination brimonidine-timolol versus brimonidine or timolol monotherapy. American journal of ophthalmology, 2011, Volume: 151, Issue:1 Topics: Antihypertensive Agents; Brimonidine Tartrate; Circadian Rhythm; Double-Blind Method; Drug Combinations; Glaucoma; Humans; Intraocular Pressure; Ocular Hypertension; Quinoxalines; Timolol; Tonometry, Ocular	2011
Effect of a fixed brimonidine-timolol combination on intraocular pressure after phacoemulsification. Journal of cataract and refractive surgery, 2011, Volume: 37, Issue:2 Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Cataract Extraction; Double-Blind Method; Drug Combinations; Female; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Male; Middle Aged; Ocular Hypertension; Phacoemulsification; Prospective Studies; Quinoxalines; Time Factors; Timolol	2011
[Effect on ocular blood flow of Combigan® versus placebo in patients with ocular hypertension]. Archivos de la Sociedad Espanola de Oftalmologia, 2011, Volume: 86, Issue:2 Topics: Aged; Brimonidine Tartrate, Timolol Maleate Drug Combination; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Intraocular Pressure; Laser-Doppler Flowmetry; Male; Middle Aged; Ocular Hypertension; Ophthalmic Artery; Ophthalmic Solutions; Prospective Studies; Quinoxalines; Regional Blood Flow; Retinal Vessels; Timolol; Ultrasonography, Doppler, Color; Vascular Resistance	2011
Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study. Current medical research and opinion, 2012, Volume: 28, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Drug Combinations; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Time Factors; Timolol; Treatment Outcome	2012
A double-masked randomized crossover study comparing the effect of latanoprost/timolol and brimonidine/timolol fixed combination on intraocular pressure and ocular blood flow in patients with primary open-angle glaucoma or ocular hypertension. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2012, Volume: 28, Issue:6 Topics: Aged; Antihypertensive Agents; Blood Flow Velocity; Brimonidine Tartrate; Cross-Over Studies; Double-Blind Method; Drug Combinations; Eye; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Laser-Doppler Flowmetry; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Time Factors; Timolol; Ultrasonography, Doppler, Color	2012
[Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections]. Journal francais d'ophtalmologie, 2012, Volume: 35, Issue:8 Topics: Acetazolamide; Aged; Antibodies, Monoclonal, Humanized; Antihypertensive Agents; Bevacizumab; Brimonidine Tartrate; Chemoprevention; Clonidine; Drug Combinations; Female; Humans; Hypotonic Solutions; Intraocular Pressure; Intravitreal Injections; Macular Degeneration; Male; Ocular Hypertension; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Treatment Outcome	2012
[Phase III clinical trial of brimonidine in patients with primary open-angle glaucoma and ocular hypertension--comparison of the effects of brimonidine monotherapy versus timolol monotherapy, or combination brimonidine/prostaglandins therapy versus combin Nippon Ganka Gakkai zasshi, 2012, Volume: 116, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins; Quinoxalines; Timolol; Treatment Outcome	2012
[Use of brimonidine 0.2% in treatment of glaucoma or ocular hypertony after poorly tolerated beta-blocker treatment]. Journal francais d'ophtalmologie, 2002, Volume: 25, Issue:6 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Appetite; Brimonidine Tartrate; Glaucoma; Humans; Intraocular Pressure; Ocular Hypertension; Patient Satisfaction; Quality of Life; Quinoxalines; Surveys and Questionnaires; Treatment Failure; Treatment Outcome	2002
Comparison of latanoprost, brimonidine and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with primary open-angle glaucoma and ocular hypertension. Acta ophthalmologica Scandinavica. Supplement, 2002, Volume: 236 Topics: Antihypertensive Agents; Brimonidine Tartrate; Circadian Rhythm; Cross-Over Studies; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular	2002
[The ocular hypotensive effect and safety of 0.2% brimonidine]. Yan ke xue bao = Eye science, 2001, Volume: 17, Issue:4 Topics: Adrenergic alpha-Agonists; Adult; Brimonidine Tartrate; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines	2001
Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability. Ophthalmology, 2003, Volume: 110, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quinoxalines; Safety; Sulfonamides; Thiophenes; Timolol; Visual Acuity; Visual Fields	2003
A 3-month comparison of efficacy and safety of brimonidine-purite 0.15% and brimonidine 0.2% in patients with glaucoma or ocular hypertension. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2003, Volume: 19, Issue:1 Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Conjunctiva; Conjunctivitis, Allergic; Dose-Response Relationship, Drug; Double-Blind Method; Glaucoma; Humans; Hyperemia; Intraocular Pressure; Ocular Hypertension; Quinoxalines; Severity of Illness Index	2003
The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Archives of ophthalmology (Chicago, Ill. : 1960), 2003, Volume: 121, Issue:4 Topics: Antihypertensive Agents; Brimonidine Tartrate; Circadian Rhythm; Cross-Over Studies; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Posture; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular	2003
Unoprostone as adjunctive therapy to timolol: a double masked randomised study versus brimonidine and dorzolamide. The British journal of ophthalmology, 2003, Volume: 87, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Chemotherapy, Adjuvant; Dinoprost; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Quinoxalines; Sulfonamides; Thiophenes; Timolol	2003
The effects of latanoprost and brimonidine on blood flow velocity of the retrobulbar vessels: a 3-month clinical trial. Acta ophthalmologica Scandinavica, 2003, Volume: 81, Issue:2 Topics: Blood Flow Velocity; Brimonidine Tartrate; Ciliary Arteries; Eye; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Artery; Prostaglandins F, Synthetic; Quinoxalines; Retinal Artery; Ultrasonography, Doppler, Color; Vascular Resistance	2003
Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily. Acta ophthalmologica Scandinavica, 2003, Volume: 81, Issue:3 Topics: Antihypertensive Agents; Brimonidine Tartrate; Circadian Rhythm; Drug Administration Schedule; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Safety; Timolol	2003
Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes. Indian journal of ophthalmology, 2003, Volume: 51, Issue:2 Topics: Adrenergic alpha-Agonists; Adult; Brimonidine Tartrate; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Treatment Outcome	2003
[The effect of brimonidine on postoperative hypertonia after an extracapsular cataract extraction]. Journal francais d'ophtalmologie, 2003, Volume: 26, Issue:4 Topics: Adrenergic alpha-Agonists; Aged; Aged, 80 and over; Brimonidine Tartrate; Cataract Extraction; Female; Humans; Male; Middle Aged; Ocular Hypertension; Postoperative Complications; Postoperative Period; Prospective Studies; Quinoxalines; Treatment Outcome	2003
Efficacy of brimonidine 0.2% in controlling acute postoperative intraocular pressure elevation after phacoemulsification. Journal of cataract and refractive surgery, 2003, Volume: 29, Issue:12 Topics: Acute Disease; Adrenergic alpha-Agonists; Aged; Antihypertensive Agents; Brimonidine Tartrate; Double-Blind Method; Female; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Lenses, Intraocular; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Prospective Studies; Quinoxalines; Treatment Outcome	2003
Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy. Eye (London, England), 2004, Volume: 18, Issue:10 Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Circadian Rhythm; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Timolol	2004
The safety and efficacy of unoprostone 0.15% versus brimonidine 0.2%. Acta ophthalmologica Scandinavica, 2004, Volume: 82, Issue:2 Topics: Antihypertensive Agents; Brimonidine Tartrate; Circadian Rhythm; Cross-Over Studies; Dinoprost; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Safety; Treatment Outcome	2004
Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension. Eye (London, England), 2005, Volume: 19, Issue:1 Topics: Antihypertensive Agents; Brimonidine Tartrate; Cross-Over Studies; Dinoprost; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Quinoxalines; Timolol; Treatment Outcome	2005
Dorzolamide/Timolol fixed combination versus concomitant administration of brimonidine and timolol in patients with elevated intraocular pressure: a 3-month comparison of efficacy, tolerability, and patient-reported measures. Journal of glaucoma, 2004, Volume: 13, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Patient Satisfaction; Prospective Studies; Quinoxalines; Safety; Sulfonamides; Thiophenes; Timolol; Treatment Outcome	2004
Comparison of the safety and efficacy of dorzolamide 2% and brimonidine 0.2% in patients with glaucoma or ocular hypertension. Journal of glaucoma, 2004, Volume: 13, Issue:2 Topics: Adrenergic alpha-Agonists; Antihypertensive Agents; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Cross-Over Studies; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quinoxalines; Safety; Sulfonamides; Thiophenes; Treatment Outcome	2004
[Efficiency of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers]. Archivos de la Sociedad Espanola de Oftalmologia, 2004, Volume: 79, Issue:4 Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quality of Life; Quinoxalines; Sulfonamides; Thiophenes; Tonometry, Ocular; Treatment Outcome	2004
A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe. The British journal of ophthalmology, 2004, Volume: 88, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; Europe; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Timolol; Treatment Outcome	2004
Brimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertension. The British journal of ophthalmology, 2004, Volume: 88, Issue:7 Topics: Antihypertensive Agents; Brimonidine Tartrate; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Quinoxalines; Sulfonamides; Thiophenes	2004
Effect of topical brinzolamide 1% and brimonidine 0.2% on intraocular pressure after phacoemulsification. Journal of cataract and refractive surgery, 2004, Volume: 30, Issue:8 Topics: Administration, Topical; Adrenergic alpha-Agonists; Aged; Aged, 80 and over; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Double-Blind Method; Female; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Prospective Studies; Quinoxalines; Sulfonamides; Thiazines; Tonometry, Ocular	2004
Latanoprost or brimonidine as treatment for elevated intraocular pressure: multicenter trial in the United States. Journal of glaucoma, 2005, Volume: 14, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Safety; Tonometry, Ocular; Treatment Outcome; United States	2005
Brimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertension. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2005, Volume: 21, Issue:4 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Double-Blind Method; Drug Combinations; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Quinoxalines; Timolol; Treatment Outcome	2005
Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery. Journal of cataract and refractive surgery, 2005, Volume: 31, Issue:9 Topics: Adrenergic alpha-Agonists; Aged; Anterior Eye Segment; Antihypertensive Agents; Blood Pressure; Brimonidine Tartrate; Clonidine; Double-Blind Method; Female; Heart Rate; Humans; Intraocular Pressure; Iridectomy; Laser Therapy; Lens Capsule, Crystalline; Male; Ocular Hypertension; Postoperative Complications; Quinoxalines; Trabeculectomy; Treatment Outcome; Visual Acuity	2005
A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension. Clinical therapeutics, 2006, Volume: 28, Issue:4 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Aged; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Cloprostenol; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Quinoxalines; Sulfonamides; Thiazines; Timolol; Travoprost	2006
An evaluation of the rate of nonresponders to latanoprost therapy. Journal of glaucoma, 2006, Volume: 15, Issue:3 Topics: Antihypertensive Agents; Brimonidine Tartrate; Cross-Over Studies; Drug Resistance; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Pilocarpine; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Timolol; Tonometry, Ocular	2006
Brimonidine 0.2% versus brimonidine Purite 0.15%: prophylactic effect on iop elevation after Nd:YAG laser posterior capsulotomy. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2006, Volume: 22, Issue:3 Topics: Aged; Brimonidine Tartrate; Double-Blind Method; Female; Humans; Intraocular Pressure; Laser Therapy; Lens Capsule, Crystalline; Male; Middle Aged; Ocular Hypertension; Postoperative Complications; Prospective Studies; Quinoxalines	2006
[Use of antiglaucoma therapy to reduce acute intraocular pressure rise following neodymium: YAG laser iridotomy in angle-closure glaucoma patients]. Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2006, Volume: 60, Issue:2 Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; Female; Glaucoma, Angle-Closure; Humans; Iris; Laser Therapy; Latanoprost; Male; Middle Aged; Miotics; Ocular Hypertension; Pilocarpine; Postoperative Complications; Prostaglandins F, Synthetic; Quinoxalines	2006
The safety and intraocular pressure-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1. Ophthalmology, 2006, Volume: 113, Issue:8 Topics: Adrenergic alpha-Agonists; Aged; Brimonidine Tartrate; Chlorine Compounds; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Oxides; Polymers; Preservatives, Pharmaceutical; Quinoxalines; Therapeutic Equivalency	2006
Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial. Archives of ophthalmology (Chicago, Ill. : 1960), 2006, Volume: 124, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quinoxalines; Timolol; Tonometry, Ocular; Treatment Outcome	2006
Comparing the fixed combination brimonidine-timolol versus fixed combination dorzolamide-timolol in patients with elevated intraocular pressure. Current medical research and opinion, 2007, Volume: 23, Issue:4 Topics: Aged; Brimonidine Tartrate; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Instillation, Drug; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Quinoxalines; Sulfonamides; Thiophenes; Timolol	2007
Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%. Ophthalmology, 2007, Volume: 114, Issue:7 Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Circadian Rhythm; Cloprostenol; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Quinoxalines; Sulfonamides; Thiazines; Travoprost; Treatment Outcome	2007
Twenty-four-hour efficacy of the brimonidine/timolol fixed combination versus therapy with the unfixed components. Eye (London, England), 2008, Volume: 22, Issue:11 Topics: Antihypertensive Agents; Brimonidine Tartrate; Cross-Over Studies; Drug Administration Schedule; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Time Factors; Timolol; Treatment Outcome	2008
Brimonidine 0.2% versus brimonidine Purite 0.15% in Asian ocular hypertension. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2007, Volume: 23, Issue:5 Topics: Administration, Topical; Adrenergic alpha-Agonists; Adult; Antihypertensive Agents; Asia; Asian People; Brimonidine Tartrate; Conjunctivitis, Allergic; Cross-Over Studies; Female; Humans; Intraocular Pressure; Male; Ocular Hypertension; Ophthalmic Solutions; Pigment Epithelium of Eye; Preservatives, Pharmaceutical; Prospective Studies; Quinoxalines; Single-Blind Method; Therapeutic Equivalency	2007
Effect of antiglaucoma agents on postoperative intraocular pressure after cataract surgery with Viscoat. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:11 Topics: Acetazolamide; Acetylcholine; Administration, Topical; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Chondroitin; Chondroitin Sulfates; Double-Blind Method; Drug Combinations; Female; Humans; Hyaluronic Acid; Intraocular Pressure; Lens Implantation, Intraocular; Male; Middle Aged; Ocular Hypertension; Phacoemulsification; Postoperative Complications; Prospective Studies; Quinoxalines; Sulfonamides; Thiazines; Timolol; Tonometry, Ocular	2007
Comparison of the effects of dorzolamide-timolol fixed combination and brimonidine on intraocular pressure after phacoemulsification surgery. Eye & contact lens, 2008, Volume: 34, Issue:1 Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Male; Ocular Hypertension; Phacoemulsification; Postoperative Care; Postoperative Complications; Prospective Studies; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Treatment Outcome	2008
Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension. Current medical research and opinion, 2008, Volume: 24, Issue:5 Topics: Adult; Aged; Analysis of Variance; Brimonidine Tartrate; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Maximum Tolerated Dose; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Organization and Administration; Probability; Prostaglandins F, Synthetic; Quinoxalines; Risk Assessment; Severity of Illness Index; Single-Blind Method; Sulfonamides; Thiazines; Tonometry, Ocular; Treatment Outcome	2008
Effects of brimonidine on aqueous humor dynamics in human eyes. Archives of ophthalmology (Chicago, Ill. : 1960), 1995, Volume: 113, Issue:12 Topics: Administration, Topical; Adrenergic alpha-Agonists; Adult; Aged; Antihypertensive Agents; Aqueous Humor; Brimonidine Tartrate; Double-Blind Method; Female; Fluorophotometry; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines	1995
The efficacy of brimonidine in decreasing elevations in intraocular pressure after laser trabeculoplasty. Ophthalmology, 1993, Volume: 100, Issue:7 Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Double-Blind Method; Drug Tolerance; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Pharmaceutical Vehicles; Quinoxalines; Trabeculectomy	1993
Brimonidine in the prevention of intraocular pressure elevation following argon laser trabeculoplasty. Archives of ophthalmology (Chicago, Ill. : 1960), 1993, Volume: 111, Issue:10 Topics: Adrenergic alpha-Agonists; Adult; Antihypertensive Agents; Brimonidine Tartrate; Double-Blind Method; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Trabeculectomy	1993
Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension. Survey of ophthalmology, 1996, Volume: 41 Suppl 1 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Blood Pressure; Brimonidine Tartrate; Double-Blind Method; Drug Administration Schedule; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Safety; Timolol; Treatment Outcome	1996
A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The Brimonidine Study Group III. Survey of ophthalmology, 1996, Volume: 41 Suppl 1 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Betaxolol; Blood Pressure; Brimonidine Tartrate; Double-Blind Method; Drug Administration Schedule; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Safety; Treatment Outcome	1996
Brimonidine tartrate: a one-month dose response study. Ophthalmology, 1997, Volume: 104, Issue:1 Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glaucoma, Open-Angle; Hemodynamics; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Pupil; Quinoxalines; Visual Acuity	1997
A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group. Archives of ophthalmology (Chicago, Ill. : 1960), 1997, Volume: 115, Issue:7 Topics: Administration, Topical; Adrenergic alpha-Agonists; Brimonidine Tartrate; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Glaucoma, Open-Angle; Hemodynamics; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Pupil; Quinoxalines; Safety; Time Factors; Timolol; Treatment Outcome; Visual Acuity	1997
Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2. Ophthalmology, 1998, Volume: 105, Issue:10 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Safety; Timolol	1998
Effect of brimonidine tartrate on ocular hemodynamic measurements. Archives of ophthalmology (Chicago, Ill. : 1960), 1998, Volume: 116, Issue:12 Topics: Adrenergic alpha-Agonists; Adult; Aged; Blood Flow Velocity; Brimonidine Tartrate; Ciliary Arteries; Cross-Over Studies; Double-Blind Method; Eye; Hemodynamics; Humans; Intraocular Pressure; Middle Aged; Ocular Hypertension; Ophthalmic Artery; Ophthalmic Solutions; Prospective Studies; Quinoxalines; Retinal Artery; Ultrasonography, Doppler, Color	1998
Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-year results in glaucoma patients. Brimonidine Study Group. American journal of ophthalmology, 1999, Volume: 127, Issue:1 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Safety; Timolol; Treatment Outcome	1999
Pressure or progression? Archives of ophthalmology (Chicago, Ill. : 1960), 1999, Volume: 117, Issue:3 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Brimonidine Tartrate; Disease Progression; Glaucoma; Humans; Intraocular Pressure; Ocular Hypertension; Quinoxalines; Timolol; Visual Fields	1999
Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures. Ophthalmic surgery and lasers, 1999, Volume: 30, Issue:3 Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Anterior Eye Segment; Brimonidine Tartrate; Chronic Disease; Clonidine; Female; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Male; Middle Aged; Observer Variation; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quinoxalines; Trabeculectomy; Treatment Outcome	1999
Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients. American journal of ophthalmology, 1999, Volume: 128, Issue:1 Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Aqueous Humor; Brimonidine Tartrate; Double-Blind Method; Female; Fluorophotometry; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Sclera; Time Factors; Venous Pressure	1999
Control of intraocular pressure elevations after argon laser trabeculoplasty: comparison of brimonidine 0.2% to apraclonidine 1.0%. Ophthalmology, 1999, Volume: 106, Issue:10 Topics: Adrenergic alpha-Agonists; Aged; Brimonidine Tartrate; Clonidine; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Laser Therapy; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quinoxalines; Trabeculectomy	1999
The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension [corrected]. American journal of ophthalmology, 1999, Volume: 128, Issue:6 Topics: Administration, Topical; Adrenergic alpha-Agonists; Blood Flow Velocity; Brimonidine Tartrate; Disease Progression; Double-Blind Method; Female; Glaucoma; Humans; Intraocular Pressure; Laser-Doppler Flowmetry; Male; Middle Aged; Ocular Hypertension; Quinoxalines; Retinal Vessels; Visual Fields	1999
The effectiveness and safety of brimonidine as mono-, combination, or replacement therapy for patients with primary open-angle glaucoma or ocular hypertension: a post hoc analysis of an open-label community trial. Glaucoma Trial Study Group. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2000, Volume: 16, Issue:1 Topics: Adrenergic alpha-Agonists; Adult; Aged; Brimonidine Tartrate; Cohort Studies; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Quinoxalines	2000
Efficacy of brimonidine as replacement therapy in patients with open-angle glaucoma or ocular hypertension. Clinical therapeutics, 2000, Volume: 22, Issue:1 Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Quality of Life; Quinoxalines; Racial Groups	2000
Ongoing clinical assessment of the safety profile and efficacy of brimonidine compared with timolol: year-three results. Brimonidine Study Group II. Clinical therapeutics, 2000, Volume: 22, Issue:1 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Blood Pressure; Brimonidine Tartrate; Double-Blind Method; Female; Glaucoma; Heart Rate; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Quinoxalines; Timolol; Vision Tests	2000
The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension. American journal of ophthalmology, 2000, Volume: 129, Issue:3 Topics: Adrenergic alpha-Agonists; Antihypertensive Agents; Blood Flow Velocity; Brimonidine Tartrate; Double-Blind Method; Female; Humans; Intraocular Pressure; Laser-Doppler Flowmetry; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Regional Blood Flow; Retinal Vessels; Visual Acuity; Visual Fields	2000
The use of topical aqueous suppressants in the prevention of postoperative intraocular pressure elevation after pars plana vitrectomy with long-acting gas tamponade. Ophthalmology, 2000, Volume: 107, Issue:3 Topics: Administration, Topical; Antihypertensive Agents; Aqueous Humor; Brimonidine Tartrate; Clonidine; Fluorocarbons; Humans; Intraocular Pressure; Ocular Hypertension; Prospective Studies; Quinoxalines; Sulfonamides; Sulfur Hexafluoride; Thiophenes; Timolol; Vitrectomy	2000
The efficacy of 0.2% brimonidine for preventing intraocular pressure rise following argon laser trabeculoplasty. Korean journal of ophthalmology : KJO, 1999, Volume: 13, Issue:2 Topics: Adrenergic alpha-Agonists; Adult; Aged; Brimonidine Tartrate; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Laser Therapy; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quinoxalines; Safety; Trabeculectomy; Treatment Outcome	1999
Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study Group. Clinical therapeutics, 2000, Volume: 22, Issue:4 Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Miotics; Ocular Hypertension; Pilocarpine; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Treatment Outcome	2000
Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2. Ophthalmology, 2000, Volume: 107, Issue:6 Topics: Administration, Oral; Administration, Topical; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Blood Pressure; Brimonidine Tartrate; Double-Blind Method; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quinoxalines; Safety; Timolol	2000
Clinical success and quality of life with brimonidine 0.2% or timolol 0.5% used twice daily in glaucoma or ocular t hypertension: a randomized clinical trial. Brimonidine Outcomes Study Group I. Journal of glaucoma, 2000, Volume: 9, Issue:3 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Blood Pressure; Brimonidine Tartrate; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Female; Glaucoma; Heart Rate; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quality of Life; Quinoxalines; Safety; Surveys and Questionnaires; Timolol; Treatment Outcome	2000
Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure. American journal of ophthalmology, 2000, Volume: 129, Issue:6 Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Cross-Over Studies; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quinoxalines; Safety; Sulfonamides; Thiophenes; Treatment Outcome	2000
[Treatment of glaucoma with brimonidine (Alphagan 0.2%)]. Journal francais d'ophtalmologie, 2000, Volume: 23, Issue:8 Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Child; Drug Therapy, Combination; Female; Glaucoma; Humans; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines	2000
Comparison of the clinical success rates and quality of life effects of brimonidine tartrate 0.2% and betaxolol 0.25% suspension in patients with open-angle glaucoma and ocular hypertension. Brimonidine Outcomes Study Group II. Journal of glaucoma, 2000, Volume: 9, Issue:5 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Betaxolol; Blood Pressure; Brimonidine Tartrate; Double-Blind Method; Drug Evaluation; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quality of Life; Quinoxalines; Safety; Suspensions; Treatment Outcome	2000
Brimonidine and postoperative pressure spikes in cataract surgery. Clinical & experimental ophthalmology, 2000, Volume: 28, Issue:5 Topics: Adrenergic alpha-Agonists; Aged; Aged, 80 and over; Brimonidine Tartrate; Cataract Extraction; Double-Blind Method; Humans; Intraocular Pressure; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Postoperative Complications; Prospective Studies; Quinoxalines; Treatment Outcome	2000
Therapeutic success of latanoprost 0.005% compared to brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertension. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2000, Volume: 16, Issue:6 Topics: Adrenergic alpha-Agonists; Adult; Antihypertensive Agents; Brimonidine Tartrate; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Retrospective Studies; Treatment Outcome	2000
The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension. American journal of ophthalmology, 2001, Volume: 131, Issue:5 Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Safety; Treatment Outcome	2001
Efficacy of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers in adult patients with glaucoma or ocular hypertension. Clinical therapeutics, 2001, Volume: 23, Issue:4 Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Brimonidine Tartrate; Cross-Over Studies; Down-Regulation; Female; Glaucoma; Humans; Immunologic Factors; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Quality of Life; Quinoxalines; Sulfonamides; Thiophenes	2001
Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery. Ophthalmology, 2001, Volume: 108, Issue:6 Topics: Adrenergic alpha-Agonists; Aged; Anterior Eye Segment; Blood Pressure; Brimonidine Tartrate; Clonidine; Double-Blind Method; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Iris; Laser Therapy; Male; Ocular Hypertension; Ophthalmic Solutions; Postoperative Complications; Quinoxalines; Safety; Trabeculectomy	2001
Effectiveness and safety of brimonidine as adjunctive therapy for patients with elevated intraocular pressure in a large, open-label community trial. Journal of glaucoma, 2001, Volume: 10, Issue:3 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Chemotherapy, Adjuvant; Community Medicine; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Quality of Life; Quinoxalines; Safety	2001
Comparison of the clinical success and quality-of-life impact of brimonidine 0.2% and betaxolol 0.25 % suspension in patients with elevated intraocular pressure. Clinical therapeutics, 2001, Volume: 23, Issue:7 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Betaxolol; Brimonidine Tartrate; Female; Humans; Intraocular Pressure; Male; Middle Aged; Multicenter Studies as Topic; Ocular Hypertension; Quality of Life; Quinoxalines; Treatment Outcome	2001
Effect of topical brimonidine on intraocular pressure after small incision cataract surgery. Journal of cataract and refractive surgery, 2001, Volume: 27, Issue:8 Topics: Administration, Topical; Adrenergic alpha-Agonists; Aged; Brimonidine Tartrate; Double-Blind Method; Female; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Male; Minimally Invasive Surgical Procedures; Ocular Hypertension; Phacoemulsification; Postoperative Complications; Prospective Studies; Quinoxalines	2001
Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal anti-inflammatory therapy. American journal of ophthalmology, 2002, Volume: 133, Issue:1 Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Blood Flow Velocity; Brimonidine Tartrate; Contrast Sensitivity; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Indomethacin; Intraocular Pressure; Laser-Doppler Flowmetry; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Retinal Vessels; Visual Fields	2002
A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial. Clinical therapeutics, 2001, Volume: 23, Issue:12 Topics: Adrenergic alpha-Agonists; Aged; Antihypertensive Agents; Brimonidine Tartrate; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Patient Satisfaction; Prostaglandins F, Synthetic; Quinoxalines; Treatment Outcome	2001
Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering. Ophthalmology, 2002, Volume: 109, Issue:2 Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Brimonidine Tartrate; Chronic Disease; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Quality of Life; Quinoxalines; Treatment Outcome	2002
Intraocular pressure-lowering effects of latanoprost and brimonidine therapy in patients with open-angle glaucoma or ocular hypertension: a randomized observer-masked multicenter study. Journal of glaucoma, 2002, Volume: 11, Issue:2 Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Treatment Outcome	2002
Twelve-month evaluation of brimonidine-purite versus brimonidine in patients with glaucoma or ocular hypertension. Journal of glaucoma, 2002, Volume: 11, Issue:2 Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Conjunctivitis, Allergic; Double-Blind Method; Drug Evaluation; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Patient Satisfaction; Preservatives, Pharmaceutical; Quality of Life; Quinoxalines; Safety	2002

Other Studies

33 other study(ies) available for quinoxalines and Ocular Hypertension

Article	Year
Intraocular pressure-lowering effects and safety of brimonidine/brinzolamide fixed combination after switching from other medications. Japanese journal of ophthalmology, 2022, Volume: 66, Issue:5 Topics: Antihypertensive Agents; Brimonidine Tartrate; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Sulfonamides; Thiazines	2022
Urrets- Zavalia Syndrome after glaucoma filtration device implantation. La Clinica terapeutica, 2013, Volume: 164, Issue:5 Topics: Acetazolamide; Aged; Brimonidine Tartrate; Cataract Extraction; Combined Modality Therapy; Drug Resistance; Drug Therapy, Combination; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Hypertension; Miotics; Mydriasis; Ocular Hypertension; Pilocarpine; Prostaglandins F; Quinoxalines; Sulfonamides; Syndrome; Thiophenes; Timolol	2013
Mechanism - based translational pharmacokinetic - pharmacodynamic model to predict intraocular pressure lowering effect of drugs in patients with glaucoma or ocular hypertension. Pharmaceutical research, 2014, Volume: 31, Issue:8 Topics: Animals; Antihypertensive Agents; Brimonidine Tartrate; Dogs; Female; Forecasting; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Models, Biological; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Rabbits; Translational Research, Biomedical; Treatment Outcome	2014
Anterior and posterior segment changes in rat eyes with chronic steroid administration and their responsiveness to antiglaucoma drugs. European journal of pharmacology, 2015, Feb-15, Volume: 749 Topics: Animals; Antihypertensive Agents; Brimonidine Tartrate; Catalase; Dexamethasone; Disease Models, Animal; Female; Glutathione; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Oxidative Stress; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Rats, Sprague-Dawley; Retina; Sulfonamides; Superoxide Dismutase; Thiophenes; Timolol	2015
Temporal evolution of intraocular pressure elevation after pupillary dilation in pigment dispersion syndrome. Journal of glaucoma, 2009, Volume: 18, Issue:3 Topics: Adult; Antihypertensive Agents; Brimonidine Tartrate; Drug Combinations; Exfoliation Syndrome; Humans; Intraocular Pressure; Male; Middle Aged; Mydriatics; Ocular Hypertension; Phenylephrine; Pupil; Quinoxalines; Retrospective Studies; Tonometry, Ocular; Tropicamide	2009
Retinal oxidative stress induced by intraocular hypertension in rats may be ameliorated by brimonidine treatment and N-acetyl cysteine supplementation. Journal of glaucoma, 2009, Volume: 18, Issue:9 Topics: Acetylcysteine; Animals; Brimonidine Tartrate; Catalase; Disease Models, Animal; Drug Therapy, Combination; Glutathione Peroxidase; Hyaluronic Acid; Intraocular Pressure; Male; Malondialdehyde; Nitric Oxide; Ocular Hypertension; Oxidative Stress; Quinoxalines; Rats; Rats, Sprague-Dawley; Retinal Diseases; Tonometry, Ocular	2009
Diurnal and nocturnal effects of brimonidine monotherapy on intraocular pressure. Ophthalmology, 2010, Volume: 117, Issue:11 Topics: Adrenergic alpha-Agonists; Aged; Antihypertensive Agents; Blood Pressure; Brimonidine Tartrate; Circadian Rhythm; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Quinoxalines	2010
The clinical impact of 2 different strategies for initiating therapy in patients with ocular hypertension. Journal of glaucoma, 2011, Volume: 20, Issue:1 Topics: Adult; Antihypertensive Agents; Blindness; Brimonidine Tartrate; Decision Trees; Disease Progression; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Markov Chains; Middle Aged; Models, Biological; Monte Carlo Method; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Risk Assessment; Sulfonamides; Thiophenes; Timolol	2011
Persistence of glaucoma medical therapy in the Glasgow Glaucoma Database. The British journal of ophthalmology, 2011, Volume: 95, Issue:7 Topics: Algorithms; Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Clinical Protocols; Databases, Factual; Drug Utilization; Female; Glaucoma; Humans; Male; Ocular Hypertension; Quinoxalines; Scotland; Timolol	2011
Asymmetry of 24-hour intraocular pressure reduction by topical ocular hypotensive medications in fellow eyes. Ophthalmology, 2011, Volume: 118, Issue:10 Topics: Administration, Topical; Adult; Aged; Antihypertensive Agents; Brimonidine Tartrate; Circadian Rhythm; Cloprostenol; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Posture; Prostaglandins F, Synthetic; Quinoxalines; Retrospective Studies; Sulfonamides; Thiazines; Timolol; Tonometry, Ocular; Travoprost	2011
Microbead-induced ocular hypertensive mouse model for screening and testing of aqueous production suppressants for glaucoma. Investigative ophthalmology & visual science, 2012, Jun-20, Volume: 53, Issue:7 Topics: Animals; Antihypertensive Agents; Aqueous Humor; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Disease Models, Animal; Drug Evaluation, Preclinical; Feasibility Studies; Intraocular Pressure; Latanoprost; Mice; Mice, Inbred C57BL; Microspheres; Muscarinic Agonists; Ocular Hypertension; Optic Nerve; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Retinal Ganglion Cells; Sulfonamides; Thiazines; Timolol; Tomography, Optical Coherence	2012
An economic analysis of switching to latanoprost from a beta-blocker or adding brimonidine or latanoprost to a beta-blocker in open-angle glaucoma or ocular hypertension. The American journal of managed care, 2002, Volume: 8, Issue:10 Suppl Topics: Adrenergic beta-Antagonists; Aged; Analysis of Variance; Antihypertensive Agents; Brimonidine Tartrate; Chi-Square Distribution; Drug Costs; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Latanoprost; Male; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Retrospective Studies	2002
A paradoxical ocular effect of brimonidine. American journal of ophthalmology, 2003, Volume: 135, Issue:1 Topics: Adrenergic alpha-Agonists; Aged; Brimonidine Tartrate; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertension; Quinoxalines	2003
Brimonidine and latanoprost as adjunctive therapy. Ophthalmology, 2003, Volume: 110, Issue:1 Topics: Antihypertensive Agents; Brimonidine Tartrate; Chemotherapy, Adjuvant; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prostaglandins F, Synthetic; Quality of Life; Quinoxalines; Randomized Controlled Trials as Topic	2003
[Clinical efficacy of 0.2% brimonidine in patients with open-angle glaucoma or ocular hypertension]. Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University, 2002, Jun-28, Volume: 27, Issue:3 Topics: Adrenergic alpha-Agonists; Adult; Brimonidine Tartrate; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quinoxalines	2002
Patient persistency with pharmacotherapy in the management of glaucoma. European journal of ophthalmology, 2003, Volume: 13 Suppl 4 Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Brimonidine Tartrate; Cohort Studies; Drug Utilization; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Middle Aged; Ocular Hypertension; Patient Compliance; Prostaglandins F, Synthetic; Quinoxalines; Retrospective Studies; Sulfonamides; Thiophenes	2003
Dermatological side effects of brimonidine: a report of three cases. The Journal of dermatology, 2003, Volume: 30, Issue:9 Topics: Administration, Topical; Adult; Aged; Antihypertensive Agents; Brimonidine Tartrate; Dermatitis, Allergic Contact; Diagnosis, Differential; Facial Dermatoses; Female; Glaucoma, Open-Angle; Humans; Lichen Planus; Male; Nail Diseases; Ocular Hypertension; Ophthalmic Solutions; Patch Tests; Quinoxalines	2003
Brimonidine and latanoprost as adjunctive therapy. Ophthalmology, 2004, Volume: 111, Issue:2 Topics: Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Timolol	2004
[Ocular hypertension in children treated with brimonidine 0.2%. A clinical study]. Archivos de la Sociedad Espanola de Oftalmologia, 2006, Volume: 81, Issue:3 Topics: Administration, Topical; Antihypertensive Agents; Brimonidine Tartrate; Child; Female; Glaucoma; Humans; Intraocular Pressure; Male; Ocular Hypertension; Quinoxalines; Retrospective Studies; Treatment Outcome	2006
A rat model for acute rise in intraocular pressure: immune modulation as a therapeutic strategy. American journal of ophthalmology, 2006, Volume: 141, Issue:6 Topics: Acute Disease; Animals; Antihypertensive Agents; Brimonidine Tartrate; Cell Survival; Disease Models, Animal; Dizocilpine Maleate; Glatiramer Acetate; Immunization; Injections; Intraocular Pressure; Male; Neuroprotective Agents; Ocular Hypertension; Optic Nerve Diseases; Peptides; Quinoxalines; Rats; Rats, Inbred Lew; Retinal Ganglion Cells; Vaccination	2006
Brimonidine/Timolol: a viewpoint by Francisco J. Goñi. Drugs & aging, 2006, Volume: 23, Issue:9 Topics: Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Ocular Hypertension; Quinoxalines; Randomized Controlled Trials as Topic; Sulfonamides; Thiophenes; Timolol; Treatment Outcome	2006
Reduced ocular allergy with fixed-combination 0.2% brimonidine-0.5% timolol. Archives of ophthalmology (Chicago, Ill. : 1960), 2007, Volume: 125, Issue:5 Topics: Antihypertensive Agents; Brimonidine Tartrate; Clinical Trials as Topic; Conjunctivitis, Allergic; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertension; Quinoxalines; Timolol	2007
Brimonidine and pupillary diameter. Ophthalmology, 1998, Volume: 105, Issue:8 Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Dose-Response Relationship, Drug; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Pupil; Quinoxalines; Safety	1998
Apparent central nervous system depression in infants after the use of topical brimonidine. American journal of ophthalmology, 1999, Volume: 128, Issue:2 Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Central Nervous System; Follow-Up Studies; Glaucoma; Humans; Infant; Infant, Newborn; Intraocular Pressure; Male; Nervous System Diseases; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines	1999
Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2000, Volume: 16, Issue:3 Topics: Administration, Topical; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Retrospective Studies; Safety; Sulfonamides; Thiophenes; Tonometry, Ocular	2000
Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma. Survey of ophthalmology, 2001, Volume: 45 Suppl 3 Topics: Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Cell Count; Cell Survival; Immunoenzyme Techniques; Intraocular Pressure; Neuroprotective Agents; Ocular Hypertension; Optic Nerve Injuries; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Retina; Retinal Ganglion Cells; Signal Transduction	2001
Washout periods for brimonidine 0.2% and latanoprost 0.005%. American journal of ophthalmology, 2001, Volume: 131, Issue:6 Topics: Adrenergic alpha-Agonists; Aged; Brimonidine Tartrate; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Single-Blind Method; Time Factors	2001
Systemic beta-blocker therapy and brimonidine and timolol. Ophthalmology, 2001, Volume: 108, Issue:8 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Brimonidine Tartrate; Clinical Trials as Topic; Glaucoma, Open-Angle; Hemodynamics; Humans; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Safety; Timolol	2001
Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Investigative ophthalmology & visual science, 2001, Volume: 42, Issue:12 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Brimonidine Tartrate; Cell Survival; Chronic Disease; Cytoprotection; Glial Fibrillary Acidic Protein; Intraocular Pressure; Laser Coagulation; Male; Neuroprotective Agents; Ocular Hypertension; Quinoxalines; Rats; Rats, Wistar; Retina; Retinal Ganglion Cells; Time Factors; Timolol	2001
Brimonidine 0.2% to prevent post laser IOP elevation. Ophthalmology, 2002, Volume: 109, Issue:5 Topics: Antihypertensive Agents; Brimonidine Tartrate; Glaucoma; Humans; Intraocular Pressure; Iris; Laser Therapy; Ocular Hypertension; Postoperative Complications; Quinoxalines; Trabeculectomy	2002
Delayed hypersensitivity to brimonidine tartrate 0.2% associated with high intraocular pressure. Eye (London, England), 2002, Volume: 16, Issue:2 Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Drug Hypersensitivity; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines	2002
Effect of hyaluronic acid on intraocular pressure in rats. Investigative ophthalmology & visual science, 2002, Volume: 43, Issue:7 Topics: Animals; Anterior Chamber; Antihypertensive Agents; Brimonidine Tartrate; Disease Models, Animal; Hyaluronic Acid; Injections; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Rats; Rats, Wistar; Timolol; Tonometry, Ocular	2002
Ocular effects of a relatively selective alpha 2 agonist (UK-14, 304-18) in cats, rabbits and monkeys. Current eye research, 1986, Volume: 5, Issue:9 Topics: Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Cats; Cebus; Eye; Female; Intraocular Pressure; Male; Neurons; Ocular Hypertension; Pupil; Quinoxalines; Rabbits; Water	1986